|
|
|
|
Cyplasin news releases
We strive to inform our investors as often as possible about what's happening with your company. At the same time, we don't wish to engage in the practice of issuing news that has no relevance. To ensure that you don't miss news of relevance, sign up for eNews messages about Cyplasin.
To view a news release, click on the title of the release below:
|
May 30, 2008
|
Cyplasin Biomedical Ltd Announces Australian Patent for the recombinant production of its Antitumor Protein
|
|
May 20, 2008
|
Cyplasin Biomedical Ltd Announces Japanese Patent for its Antitumor Protein
|
|
January 18, 2008
|
Cyplasin Announces Commencement of Second Animal Efficacy Study
|
|
January 11, 2008
|
Cyplasin Announces Financing
|
|
December 7, 2007
|
Year End Review plus Manufacturer (CMO) Updates
|
|
November 16, 2007
|
Cyplasin enters negotiations with manufacturing organizations for scale up and GMP manufacture of Cyplasin-SC™
|
|
November 2, 2007
|
Cyplasin Biomedical Ltd Announces Second U.S. Patent for Cyplasin
|
|
October 12, 2007
|
Cyplasin-SC™ shows proof of efficacy in tumor bearing animals
|
|
October 5, 2007
|
Cyplasin-SC™ Enters Next Phase of Efficacy Testing
|
|
September 4, 2007
|
Cyplasin-SC™ kills melanoma cells, even derived from different patients, but leaves normal human cells unharmed
|
|
|
|
|
|
|
Receive News Updates
Subscribe to eNews updates from Cyplasin. You may unsubscribe at any time.
|
|
|
